NASDAQ
BioMark Diagnostics Inc. (BMKDF) has a price/sales ratio of 156.92x as of Friday, May 22, 2026. This represents a 2.51% increase compared to its 12-month average of 153.08x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.